Page 36 - Read Online
P. 36

Chu et al. J Transl Genet Genom 2022;6:290-303  https://dx.doi.org/10.20517/jtgg.2022.02  Page 302

               vision “To avail genomic medicine to all for better health and well-being”.


               DECLARATIONS
               Acknowledgments
               We would like to thank all members of the HKGI in preparing the launch of the HKGP. This work would
               not have been possible without the instrumental leadership and guidance from Dr Su-vui Lo, Chief
               Executive Officer. We extend our gratitude to the Board of Directors and Advisory Committees for their
               continuous support and advice. We also wish to acknowledge the support of the HKGP stakeholders: the
               Food and Health Bureau; Hospital Authority; Department of Health; and Partnering Centres at The
               University of Hong Kong/Queen Mary Hospital, The Chinese University of Hong Kong/Prince of Wales
               Hospital, and Hong Kong Children's Hospital.


               Authors’ contributions
               Contributed intellectually and practically to this piece: Chu ATW, Fung JLF, Tong AHY, Chow SM, Chan
               KYK, Yeung KS, Lo HM, Hong Kong Genome Project, Chung BHY


               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               Not applicable.


               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2022.


               REFERENCES
               1.       Chung BHY, Chau JFT, Wong GK. Rare versus common diseases: a false dichotomy in precision medicine. NPJ Genom Med
                   2021;6:19.  DOI  PubMed  PMC
               2.       Smedley D, Smith KR, Martin A, et al; 100; 000 Genomes pilot on rare-disease diagnosis in health care - preliminary report.
                   N Engl J Med 2021;385:1868-80.  DOI  PubMed
               3.       Stark Z, Schofield D, Martyn M, et al. Does genomic sequencing early in the diagnostic trajectory make a difference? Genet Med
                   2019;21:173-80.  DOI  PubMed
               4.       Wise AL, Manolio TA, Mensah GA, et al. Genomic medicine for undiagnosed diseases. Lancet 2019;394:533-40.  DOI  PubMed
                   PMC
               5.       Turro E, Astle WJ, Megy K, et al; Whole-genome sequencing of patients with rare diseases in a national health system.
                   Nature 2020;583:96-102.  DOI  PubMed  PMC
               6.       Wheway G, Mitchison HM, Ambrose JC, et al. Opportunities and challenges for molecular understanding of ciliopathies - the 100,000
                   genomes project. Front Genet 2019;10:127.  DOI  PubMed  PMC
               7.       Swanson CL, Kumar A, Maharaj JM, et al. Increasing genetic counseling referral rates through bundled interventions after ovarian
                   cancer diagnosis. Gynecol Oncol 2018;149:121-6.  DOI  PubMed
               8.       Dragojlovic N, Borle K, Kopac N, et al. The composition and capacity of the clinical genetics workforce in high-income countries: a
                   scoping review. Gene Med 2020;22:1437-49.  DOI
   31   32   33   34   35   36   37   38   39   40   41